MA51913A - Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire - Google Patents

Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire

Info

Publication number
MA51913A
MA51913A MA051913A MA51913A MA51913A MA 51913 A MA51913 A MA 51913A MA 051913 A MA051913 A MA 051913A MA 51913 A MA51913 A MA 51913A MA 51913 A MA51913 A MA 51913A
Authority
MA
Morocco
Prior art keywords
granular composition
improving
producing
elution property
granular
Prior art date
Application number
MA051913A
Other languages
English (en)
Inventor
Toshinori Tanaka
Rie Yamada
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of MA51913A publication Critical patent/MA51913A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
MA051913A 2018-02-21 2019-02-20 Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire MA51913A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018029093 2018-02-21

Publications (1)

Publication Number Publication Date
MA51913A true MA51913A (fr) 2020-12-30

Family

ID=67687749

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051913A MA51913A (fr) 2018-02-21 2019-02-20 Composition granulaire, procédé de production d'une composition granulaire et procédé d'amélioration de la propriété d'élution d'une composition granulaire

Country Status (21)

Country Link
US (1) US20200397700A1 (fr)
EP (1) EP3756670A4 (fr)
JP (4) JP7430629B2 (fr)
KR (1) KR20200123447A (fr)
CN (1) CN112055591A (fr)
AR (1) AR114399A1 (fr)
AU (1) AU2019225516A1 (fr)
BR (1) BR112020016230A2 (fr)
CA (1) CA3091584A1 (fr)
CL (1) CL2020002129A1 (fr)
CO (1) CO2020011034A2 (fr)
EC (1) ECSP20057951A (fr)
IL (1) IL276732A (fr)
MA (1) MA51913A (fr)
MX (1) MX2020008695A (fr)
PE (1) PE20210448A1 (fr)
PH (1) PH12020551285A1 (fr)
RU (1) RU2020130411A (fr)
SG (1) SG11202007967YA (fr)
TW (1) TW201936175A (fr)
WO (1) WO2019163822A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7646646B2 (ja) * 2019-10-23 2025-03-17 日本新薬株式会社 セレキシパグを含む医薬組成物
JP6989064B1 (ja) * 2020-04-10 2022-01-05 日本新薬株式会社 固形製剤及びその製造方法
TW202604503A (zh) * 2024-05-27 2026-02-01 日商日本新藥股份有限公司 賽樂西帕錠劑及其製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2654197B2 (ja) * 1989-09-25 1997-09-17 三菱電機株式会社 スターリングエンジンの圧縮機駆動装置
JP2002097153A (ja) 2000-09-19 2002-04-02 Tadao Miyasaka グルタチオン含有酵母エキスを含む組成物
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
TWI316055B (fr) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
ATE405170T1 (de) * 2003-05-06 2008-09-15 Gumlink As Methode zur herstellung von kaugummigranulat und komprimierten kaugummiprodukten, sowie ein kaugummigranuliersystem
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
JP2011153075A (ja) 2008-04-04 2011-08-11 Shionogi & Co Ltd 水懸濁性を向上させた細粒剤
SG176915A1 (en) * 2009-06-26 2012-01-30 Nippon Shinyaku Co Ltd Crystals
JP6349306B2 (ja) 2013-04-25 2018-06-27 杏林製薬株式会社 錠剤
SG11201804320QA (en) * 2015-12-02 2018-06-28 Nippon Shinyaku Co Ltd Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide
WO2017121806A1 (fr) * 2016-01-15 2017-07-20 Sandoz Ag Composition pharmaceutique de selexipag

Also Published As

Publication number Publication date
JP2023182650A (ja) 2023-12-26
KR20200123447A (ko) 2020-10-29
AR114399A1 (es) 2020-09-02
JP7809780B2 (ja) 2026-02-02
JP7639092B2 (ja) 2025-03-04
EP3756670A4 (fr) 2021-11-03
IL276732A (en) 2020-09-30
JP7430629B2 (ja) 2024-02-13
BR112020016230A2 (pt) 2020-12-08
EP3756670A1 (fr) 2020-12-30
CN112055591A (zh) 2020-12-08
JP2025024023A (ja) 2025-02-19
SG11202007967YA (en) 2020-09-29
RU2020130411A3 (fr) 2022-03-21
US20200397700A1 (en) 2020-12-24
CL2020002129A1 (es) 2021-02-05
PH12020551285A1 (en) 2021-05-31
CO2020011034A2 (es) 2020-12-10
PE20210448A1 (es) 2021-03-08
CA3091584A1 (fr) 2019-08-29
JP2026067934A (ja) 2026-04-21
MX2020008695A (es) 2020-09-25
ECSP20057951A (es) 2020-10-30
AU2019225516A1 (en) 2020-10-08
RU2020130411A (ru) 2022-03-21
JPWO2019163822A1 (ja) 2021-02-04
WO2019163822A1 (fr) 2019-08-29
TW201936175A (zh) 2019-09-16

Similar Documents

Publication Publication Date Title
EP3626803A4 (fr) Composition et procédé de production d'une composition
EP3730534A4 (fr) Copolymère de polycarbonate-polydiorganosiloxane, composition de résine de copolymère de polycarbonate-polydiorganosiloxane, et procédé de production d'une composition de résine de copolymère de polycarbonate-polydiorganosiloxane
EP3611285A4 (fr) Plaque d'acier et son procédé de production
MA50859A (fr) Procédé pour la production d'une composition de lymphocytes t
EP3603823A4 (fr) Plaque d'acier revêtue et procédé de production associé
EP3604597A4 (fr) Tôle d'acier plaquée et son procédé de production
EP3974456A4 (fr) Composition de résine, procédé de production d'une composition de résine et article moulé
EP3588654A4 (fr) Procédé de production d'une monocellule
EP3758500A4 (fr) Procédé de production d'une composition de chocolat, produit de chocolaterie et composition de chocolat
EP3467034A4 (fr) Composition de résine, procédé de production d'une composition de résine, et objet moulé
EP3623398A4 (fr) Copolymère à blocs modifié, procédé de production d'un copolymère à blocs modifié, et composition de résine
EP3527593A4 (fr) Composition d'isocyanate, procédé de production de composition d'isocyanate, et procédé de production de polymère d'isocyanate
EP4023804A4 (fr) Procédé de production d'articles fibreux
MA48798A (fr) Procédé de production d'ozanimod
EP3382051A4 (fr) Acier, constituant d'acier cémenté, et procédé de production de constituant d'acier cémenté
EP3382050A4 (fr) Acier, constituant d'acier cémenté, et procédé de production de constituant d'acier cémenté
EP4079755A4 (fr) Procédé de production d'organoïde
EP3392307A4 (fr) Procédé de production d'une composition de résine de polyacétal
EP3492073A4 (fr) Matériau d'application pour la muqueuse buccale et son procédé de production.
EP3535302A4 (fr) Procédé de production d'un caoutchouc diénique modifié, caoutchouc, et composition associée
EP3995475A4 (fr) Procédé de production de 1,3-butadiène
EP3399046A4 (fr) Mélange d'a-glucane, procédé de production dudit mélange, et application dudit mélange
EP3867354A4 (fr) Compositions et procédés de production d'organoïdes tumoraux
EP3647371A4 (fr) Composition de résine, procédé de production d'une composition de résine, et article moulé
EP3778560A4 (fr) Procédé de production d'acrylonitrile